With Covid deaths rising to about 1,500 per week, researchers question why Paxlovid use has remained low among high-risk patients.
Tag: Paxlovid (Drug)
-
The C.D.C. Director on Why You Should Get the Latest Covid Booster
Here’s why the latest booster is recommended for more Americans.
-
How Nursing Homes Failed to Protect Residents From Covid
A series of hurdles prevented the facilities from shielding older people, despite the best efforts of staff. Experts are calling for reforms before the next virus arrives.
-
F.D.A. Advisers Endorse Paxlovid’s Benefits as a Covid Treatment
While an agency analysis did find signs of Covid “rebound,” the drug significantly reduces hospitalizations and deaths, researchers said.
-
Why the Odds Are Stacked Against a Promising New Covid Drug
A new drug quashes all coronavirus variants. But regulatory hurdles and a lack of funding make it unlikely to reach the U.S. market anytime soon.